Obesity Management ECHO #8.4 | Genetic Testing for Obesity

Please fill out the following feedback survey (it will take no longer than 5 minutes to complete).

Your feedback is important to us - it will help us improve the Paediatric Project ECHO Program and maintain Continuing Professional Development (CPD) accreditation.

Session Details
Session: 8.4
Topic: Genetic Testing for Obesity: What should this conversation with patients look like?
Date: April 24th, 2025
Speaker: Riyana Babul-Hirji, MSc, Genetic Counsellor, SickKids

Learning Objectives:

By the end of this session, participants will:

Explain the genetics of obesity
Identify key considerations when discussing genetic testing with families as part of the informed consent process

Question Title

1. Please share your ECHO session experience:

	Strongy Disagree	Disagree	Neutral	Agree	Strongly Agree
This session met its stated learning objectives.	This session met its stated learning objectives. Strongy Disagree	This session met its stated learning objectives. Disagree	This session met its stated learning objectives. Neutral	This session met its stated learning objectives. Agree	This session met its stated learning objectives. Strongly Agree
This session enhanced my knowledge.	This session enhanced my knowledge. Strongy Disagree	This session enhanced my knowledge. Disagree	This session enhanced my knowledge. Neutral	This session enhanced my knowledge. Agree	This session enhanced my knowledge. Strongly Agree
The speaker was effective in delivering the session didactic.	The speaker was effective in delivering the session didactic. Strongy Disagree	The speaker was effective in delivering the session didactic. Disagree	The speaker was effective in delivering the session didactic. Neutral	The speaker was effective in delivering the session didactic. Agree	The speaker was effective in delivering the session didactic. Strongly Agree
Session was balanced and unbiased.	Session was balanced and unbiased. Strongy Disagree	Session was balanced and unbiased. Disagree	Session was balanced and unbiased. Neutral	Session was balanced and unbiased. Agree	Session was balanced and unbiased. Strongly Agree
Relevance to overall practice.	Relevance to overall practice. Strongy Disagree	Relevance to overall practice. Disagree	Relevance to overall practice. Neutral	Relevance to overall practice. Agree	Relevance to overall practice. Strongly Agree
There was enough time for active learning.	There was enough time for active learning. Strongy Disagree	There was enough time for active learning. Disagree	There was enough time for active learning. Neutral	There was enough time for active learning. Agree	There was enough time for active learning. Strongly Agree

Question Title

2. Did you perceive any degree of bias in any part of the program? (The National Standard defines bias as “a predisposition that prevents impartiality or which promotes an unfair, limited, or prejudiced viewpoint”)

Yes, speaker and/or program funding

Yes, mention of specific pharmaceuticals or products within the program content

Yes, expression of personal opinions creating undue influence

Other

If other, please explain:

Question Title

3. Please indicate which of the CanMEDS-FM/CanMEDS roles you felt were addressed during this session: (select all that apply)

Medical Expert

Communicator

Collaborator

Leader

Health Advocate

Scholar

Professional

Question Title

4. What will you do differently in your practice/work as a result of this session?

Question Title

5. Can you identify any barriers to incorporating what you learned today into your practice/work? (select one)

Yes

Question Title

6. If yes, what?

Question Title

7. We understand that engagement looks different to different people. Engagement can include talking, writing in the chat or just actively listening. Overall, how would you rate your engagement during the program?

Not engaged at all

Somewhat disengaged

Neutral

Somewhat engaged

Very engaged

Question Title

8. What, if anything, contributed to your engagement?

Question Title

9. What, if anything, was a barrier to your engagement?

Question Title

10. What changes would you like to see to this didactic presentation?

Question Title

11. Are there any topics that you would like to suggest for future sessions?

Question Title

12. Are you currently working on any challenging cases in your practice or clinical setting?

Yes

Obesity Management ECHO #8.4 | Genetic Testing for Obesity

Question Title

1. Please share your ECHO session experience:

Question Title

2. Did you perceive any degree of bias in any part of the program? (The National Standard defines bias as “a predisposition that prevents impartiality or which promotes an unfair, limited, or prejudiced viewpoint”)

Question Title

3. Please indicate which of the CanMEDS-FM/CanMEDS roles you felt were addressed during this session: (select all that apply)

Question Title

Question Title

4. What will you do differently in your practice/work as a result of this session?

Question Title

5. Can you identify any barriers to incorporating what you learned today into your practice/work? (select one)

Question Title

6. If yes, what?

Question Title

7. We understand that engagement looks different to different people. Engagement can include talking, writing in the chat or just actively listening. Overall, how would you rate your engagement during the program?

Question Title

8. What, if anything, contributed to your engagement?

Question Title

9. What, if anything, was a barrier to your engagement?

Question Title

10. What changes would you like to see to this didactic presentation?

Question Title

11. Are there any topics that you would like to suggest for future sessions?

Question Title

12. Are you currently working on any challenging cases in your practice or clinical setting?

Question Title

13. If so, can the ECHO team follow-up with you about this? Please provide an email if you are interested in this.

Question Title

14. Do you have any feedback or suggestions for improvement?

Question Title

15. On a scale of 1-10, how likely are you to recommend Paediatric Project ECHO to your colleagues?